Philippe Busque - Aug 28, 2023 Form 3 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
SVP, Global Sales and Services
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Philippe Busque
Stock symbol
CTKB
Transactions as of
Aug 28, 2023
Transactions value $
$0
Form type
3
Date filed
8/29/2023, 06:01 PM
Next filing
Mar 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTKB Restricted Stock Units Aug 28, 2023 Common Stock 24.6K Direct F1, F2
holding CTKB Restricted Stock Units Aug 28, 2023 Common Stock 5.46K Direct F2, F3
holding CTKB Employee Stock Option (right to buy) Aug 28, 2023 Common Stock 37.6K $9.15 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the Restricted Stock Units (the "RSU Award") shall vest over four years with 13/48 of the total shares underlying the RSU Award vesting on May 18, 2024; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; 4/48 of the total shares underlying the RSU Award vesting on March 10, 2025 and each March 10 thereafter; and 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter.
F2 Each RSU Award represents a contingent right to receive one share of the Issuer's common stock.
F3 The shares subject to the RSU Award shall vest on March 20, 2024.
F4 The shares subject to the option vest as follows: 25% of the shares subject to the option vests on March 20, 2024; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.